Skip to main content

Animations

MJFF Publications

4071 - 4080 of 6516 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2021
  • 2021
  • 2022
  • 2022
  • 2022
  • 2022
  • 2021
  • 2022
  • Summary Details
    OPEN
    Title: Plcg2M28L Interacts With High Fat/High Sugar Diet to Accelerate Alzheimer’s Disease-Relevant Phenotypes in Mice
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2022.886575
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Cathepsin B p.Gly284Val Variant in Parkinson’s Disease Pathogenesis
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms23137086
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.28792
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Lower Circulating Lymphocyte Count Predicts ApoEε4‐Related Cognitive Decline in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28799
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Coffee, smoking and aspirin are associated with age at onset in idiopathic Parkinson’s disease
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00415-022-11041-x
    Citation Count: 35
  • Summary Details
    OPEN
    Title: A data-driven model of brain volume changes in progressive supranuclear palsy
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcac098
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Uncovering clinical and radiological asymmetry in progressive supranuclear palsy—Richardson’s syndrome
    Journal Name: Neurological Sciences
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s10072-022-05919-x
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Intracerebral administration of a modified antisense oligonucleotide targeting the dopamine system in a mouse model of Parkinson’s disease
    Journal Name: STAR Protocols
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.xpro.2022.101445
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Disruption of mitochondrial complex I induces progressive parkinsonism
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41586-021-04059-0
    Citation Count: 532
  • Summary Details
    OPEN
    Title: Astrocytic α2-Na + /K + ATPase inhibition suppresses astrocyte reactivity and reduces neurodegeneration in a tauopathy mouse model
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.abm4107
    Citation Count: 73
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.